Medical Research
(H400)
IRS Verified
DX Registered
990 on File
NATIONAL SCLERODERMA FOUNDATION
Financial strength (30%)
67/100
Reliability (20%)
70/100
Effectiveness (25%)
65/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$6.6M
Total Revenue
$6.8M
Total Expenses
$8.3M
Net Assets
33
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
63.1%
Fundraising Efficiency
922.4%
Operating Reserve
14.74x
Liability-to-Asset
26.0%
Revenue Diversification
84.4%
Executive Compensation
$550K
Compared with Peers
FY 2025
Compared with 132 similar organizations
(United States, Medical Research, $1M–$10M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
63.1% | 83.0% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
17.7% | 9.9% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
19.1% | 2.6% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
922.4% | 110.6% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
14.7 mo | 14.4 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
26.0% | 13.2% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
84.4% | 90.0% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
34.1% | 7.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-2.5% | 3.0% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-2.3% | 4.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $6.6M | $6.8M | $8.3M | 63.1% | 33 |
| 2024 | $4.9M | $7.0M | $8.4M | 67.7% | 35 |
| 2023 | $6.9M | $6.5M | $9.8M | 73.5% | 33 |
| 2022 | $4.6M | $6.2M | N/A | — | 0 |
| 2021 | $4.2M | $4.5M | N/A | — | 24 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.